GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fuse Medical Inc (OTCPK:FZMD) » Definitions » Beneish M-Score

Fuse Medical (Fuse Medical) Beneish M-Score : -1.55 (As of May. 29, 2024)


View and export this data going back to . Start your Free Trial

What is Fuse Medical Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.55 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Fuse Medical's Beneish M-Score or its related term are showing as below:

FZMD' s Beneish M-Score Range Over the Past 10 Years
Min: -20.54   Med: -2.33   Max: 42.01
Current: -1.55

During the past 13 years, the highest Beneish M-Score of Fuse Medical was 42.01. The lowest was -20.54. And the median was -2.33.


Fuse Medical Beneish M-Score Historical Data

The historical data trend for Fuse Medical's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fuse Medical Beneish M-Score Chart

Fuse Medical Annual Data
Trend Aug13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.36 -3.46 -3.10 -2.87 -1.75

Fuse Medical Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.34 -2.40 -1.75 -1.47 -1.55

Competitive Comparison of Fuse Medical's Beneish M-Score

For the Medical Devices subindustry, Fuse Medical's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fuse Medical's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fuse Medical's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Fuse Medical's Beneish M-Score falls into.



Fuse Medical Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Fuse Medical for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.2291+0.528 * 0.8951+0.404 * 1.1285+0.892 * 0.9423+0.115 * 0.2264
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9675+4.679 * 0.186924-0.327 * 1.0506
=-1.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun23) TTM:Last Year (Jun22) TTM:
Total Receivables was $3.43 Mil.
Revenue was 4.997 + 3.984 + 4.886 + 4.537 = $18.40 Mil.
Gross Profit was 3.469 + 2.816 + 2.613 + 3.055 = $11.95 Mil.
Total Current Assets was $12.82 Mil.
Total Assets was $19.32 Mil.
Property, Plant and Equipment(Net PPE) was $0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.13 Mil.
Selling, General, & Admin. Expense(SGA) was $12.13 Mil.
Total Current Liabilities was $12.06 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.
Net Income was 0.308 + -0.228 + 3.559 + -0.009 = $3.63 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = $0.00 Mil.
Cash Flow from Operations was -0.099 + 0.331 + -0.831 + 0.618 = $0.02 Mil.
Total Receivables was $2.97 Mil.
Revenue was 4.668 + 4.554 + 6.058 + 4.251 = $19.53 Mil.
Gross Profit was 2.64 + 2.811 + 3.514 + 2.389 = $11.35 Mil.
Total Current Assets was $13.02 Mil.
Total Assets was $19.05 Mil.
Property, Plant and Equipment(Net PPE) was $0.35 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.10 Mil.
Selling, General, & Admin. Expense(SGA) was $13.31 Mil.
Total Current Liabilities was $11.33 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(3.434 / 18.404) / (2.965 / 19.531)
=0.18659 / 0.15181
=1.2291

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(11.354 / 19.531) / (11.953 / 18.404)
=0.581332 / 0.649478
=0.8951

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (12.819 + 0) / 19.318) / (1 - (13.021 + 0.352) / 19.053)
=0.336422 / 0.298116
=1.1285

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=18.404 / 19.531
=0.9423

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.103 / (0.103 + 0.352)) / (0.134 / (0.134 + 0))
=0.226374 / 1
=0.2264

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(12.133 / 18.404) / (13.309 / 19.531)
=0.659259 / 0.68143
=0.9675

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 12.064) / 19.318) / ((0 + 11.325) / 19.053)
=0.624495 / 0.594395
=1.0506

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(3.63 - 0 - 0.019) / 19.318
=0.186924

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Fuse Medical has a M-score of -1.55 signals that the company is likely to be a manipulator.


Fuse Medical Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Fuse Medical's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Fuse Medical (Fuse Medical) Business Description

Traded in Other Exchanges
N/A
Address
1565 N. Central Expressway, Suite 220, Richardson, TX, USA, 75080
Fuse Medical Inc is a manufacturer and distributor of medical devices. The company provides a comprehensive portfolio of products in the orthopedic total joints, sports medicine, trauma, foot and ankle space, as well as degenerative and deformity spine, orthobiologics, and regenerative medicine.
Executives
Lawrence Scott Yellin director, officer: Chief Financial Officer 5081 PINEVIEW CIRCLE, DELRAY BEACH FL 33445
Christopher C Reeg director, 10 percent owner, officer: Chief Executive Officer 3024 WESTMINSTER AVE, DALLAS TX 75205
Reeg Medical Industries, Inc. 10 percent owner 3024 WESTMINSTER AVE., DALLAS TX 75205
Mark W Brooks 10 percent owner 1565 NORTH CENTRAL EXPRESSWAY, SUITE 200, RICHARDSON TX 75080
Bosita Renato V. Jr. director TEXAS BACK INSTITUTE, 6020 WEST PARKER ROAD #200, PLANO TX 75025
Kalra Ricky Raj S. director 2513 SUNTREE LANE, PLANO TX 75025
Nc 143 Family Holdings, Lp 10 percent owner 1565 NORTH CENTRAL EXPRESSWAY, SUITE 200, RICHARDSON TX 75080
Medtech Family Trust 10 percent owner 1565 NORTH CENTRAL EXPRESSWAY, SUITE 200, RICHARDSON TX 75080
Mclaughlin William E Iii director 1565 NORTH CENTRAL EXPRESSWAY, 2ND FLOOR, RICHARDSON TX 75080
Nc 143 Family Holdings Gp Llc 10 percent owner 1565 NORTH CENTRAL EXPRESSWAY, SUITE 200, RICHARDSON TX 75080
Chris Pratt director, 10 percent owner, officer: Chief Medical Officer 4770 BRYANT IRVIN COURT, SUITE 300, FORT WORTH TX 76107
Randall Dei director, officer: Medical Director of Podiatry 4770 BRYANT IRVIN COURT, SUITE 300, FORT WORTH TX 76107
Rusty Shelton director, 10 percent owner, officer: Chief Development Officer 4770 BRYANT IRVIN COURT, SUITE 300, FORT WORTH TX 76107
David Hexter director, officer: Interim CFO 4770 BRYANT IRVIN COURT, SUITE 300, FORT WORTH TX 76107
D Alan Meeker director, 10 percent owner, officer: Chief Executive Officer 4770 BRYANT IRVIN COURT, SUITE 400, FORT WORTH TX 76107

Fuse Medical (Fuse Medical) Headlines

From GuruFocus